Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Fluorouracil and Oxaliplatin With or Without Panitumumab In Treating Patients With High-Risk Colon Cancer That Can Be Removed by Surgery
The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2008
by National Cancer Institute (NCI).
Recruitment status was Recruiting
Study NCT00647530 Information provided by National Cancer Institute (NCI)
First Received on March 28, 2008. Last Updated on February 13, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Colorectal Cancer
Additional conditions recognized in this trial
Colonic Neoplasms
Colorectal Neoplasms
More general conditions related to this trial
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Neoplasms
Neoplasms by Site
Rectal Diseases
Interventions listed in this trial
panitumumab
capecitabine
fluorouracil
oxaliplatin
fluorescence in situ hybridization
gene expression analysis
microarray analysis
polymerase chain reaction
proteomic profiling
western blotting
adjuvant therapy
neoadjuvant therapy
quality-of-life assessment
therapeutic conventional surgery
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Birmingham Clinical Trials Unit
Back to top of Main Content
